[The prevention of alcohol withdrawal syndrome (author's transl)].
The study on the effect of the "tiapride" on the elements due to the withdrawal syndrome effected on thirty alcoholic patients allows us to draw the following results: failure, 13% studied cases; partial results, 50% very good results, 37%. The effect on the shivering was considered as good, but the effect on insomnia and anxiety was moderate. It appears that the doses which have been used are unsufficient to use this medecine as a "monotherapy". The authors intend to carry on this study using more important doses, taking into account the excellent tolerance observed.
D000328:Adult; D000437:Alcoholism / Q000534:rehabilitation*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D014202:Tremor / Q000188:drug therapy
D014150:Antipsychotic Agents; D001549:Benzamides
La prévention du syndrome de sevrage.